|
KMID : 0939920190510031231
|
|
대한암학회지
2019 Volume.51 No. 3 p.1231 ~ p.1240
|
|
|
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
|
|
Kim Su-Jung
Kim So-Yeon
Kim Dong-Wan
Kim Mi-So
Keam Bhum-Suk
Kim Tae-MIn
Lee Yu-Soo
Koh Jae-Moon
Jeon Yoon-Kyung
Heo Dae-Seog
|
|
|
Abstract
|
|
|
Purpose: The purpose of this study was to evaluate the relationships between the resistance of anaplastic lymphoma kinase (ALK)?positive non-small cell lung cancer (NSCLC) to ALK inhibitors and the programmed cell death-1/programmed cell death?ligand 1 (PD-L1) pathway, we evaluated alterations in PD-L1 following acquisition of resistance to ALK inhibitors in ALK-positive lung cancer.
Materials and Methods: We established ALK inhibitor-resistant cell lines (H3122CR1, LR1, and CH1) by exposing the parental H3122 ALK-translocated NSCLC cell line to ALK inhibitors. Then, the double-resistant cell lines H3122CR1LR1 and CR1CH1 were developed by exposing the H3122CR1 to other ALK inhibitors. We compared the alterations in PD-L1 expression levels using western blotting, flow cytometry, and quantitative polymerase chain reaction. We also investigated gene expression using RNA sequencing. The expression of PD-L1 in the tumors from 26 ALK-positive metastatic NSCLC patients (11 ALK inhibitor-naive and 15 ALK inhibitor-resistant patients) was assessed by immunohistochemistry and analyzed.
Results: PD-L1 was expressed at higher levels in ALK inhibitor-resistant cell lines than in the ALK inhibitor-naive parental cell line at the total protein, surface protein, and mRNA levels. Furthermore, PD-L1 expression in the double-resistant cell lines was much higher than that in the single resistant cell lines. RNA sequencing demonstrated that expression of immune-related genes were largely involved in ALK inhibitor resistance. The mean value of the PD-L1 H-score was 6.5 pre-treatment and 35.0 post-treatment, and the fold difference was 5.42 (p=0.163).
Conclusion: PD-L1 expression increased following acquisition of ALK inhibitor resistance in ALK-positive NSCLC cell lines and tumors.
|
|
|
KEYWORD
|
|
|
Anaplastic lymphoma kinase, Lung neoplasms, Drug resistance, B7-H1 antigen
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
    
|